Local botulinum toxin type A injections in the treatment of spastic toes

American Journal of Physical Medicine and Rehabilitation

Volumn 81, Issue 10, 2002, Pages 770-775

  Suputtitada, Areerat ^a  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Botulinum Toxin Type A; Modified Ashworth Scale; Spastic Toes

Indexed keywords

BIOLOGICAL ORGANS; DISEASES;

SPASTICITY;

PATIENT TREATMENT;

BOTULINUM TOXIN A;

ADULT; ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; EXTENSOR MUSCLE; FEMALE; FLEXOR MUSCLE; HEMIPLEGIA; HUMAN; INFANTILE SPASM; MALE; RISK BENEFIT ANALYSIS; SPASTICITY; TOE; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; BOTULINUM TOXIN TYPE A; BRAIN INJURIES; CEREBROVASCULAR ACCIDENT; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROMYOGRAPHY; FEMALE; HEMIPLEGIA; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MUSCLE SPASTICITY; NEUROMUSCULAR AGENTS; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOES; TREATMENT OUTCOME; WALKING;

EID: 0036788324     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002060-200210000-00009     Document Type: Article

References (9)

1. Gracies JM, Elovic E, McGuire J, et al: Traditional pharmacological treatments for spasticity: Part II. General and regional treatments. Muscle Nerve 1997; 20(suppl 6):S92-S120
2. Gracies JM, Elovic E, McGuire J, et al: Traditional pharmacological treatments for spasticity: Part 1. Local treatments. Muscle Nerve 1997;20(suppl 6):S61-S91
3. Simpson LL: Current concepts on the mechanism of action of clostridial neurotoxins, in Das Gupta BR (ed): Botulinum and Tetanus Neurotoxins. New York, Plenum Press, 1993, pp 5-15
4. Das TK, Park DM: Effect of treatment with botulinum toxin on spasticity. Postgrad Med J 1989;65:208-10
5. Demger R, Neyer U, Wonifarth K, et al: Local botulinum toxin in the treatment of spastic drop foot. J Neurol 1992;239: 375-8
6. Brin MF, The Spasticity Study Group: Dosing administration, and a treatment algorithm for use of botulinum toxin A for adult-onset spasticity. Muscle Nerve 1997;20(suppl 6):S208-S220
7. Simpson DM, Alexander ND, O'Brian CP, et al: Botulinum toxin type A in the treatment of upper extremity spasticity, randomized, double-blind, placebo controlled trial. Neurology 1996;46:1306-10
8. Yablon SA, Agana BT, Ivanhoe CB, et al: Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: An open-labeled trial. Neurology 1996;47:939-44
9. Koman LA, Mooney JF III, Smith BP, et al: Management of spasticity in cerebral palsy with botulinum A toxin: Report of a preliminary, randomized, double-blind trial. J Pediatr Orthop 1994;14: 299-303